Cargando…

Efficient and Easy Conversion of Human iPSCs into Functional Induced Microglia-like Cells

Current protocols converting human induced pluripotent stem cells (iPSCs) into induced microglia-like cells (iMGL) are either dependent on overexpression of transcription factors or require substantial experience in stem-cell technologies. Here, we developed an easy-to-use two-step protocol to conve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lanfer, Jonas, Kaindl, Johanna, Krumm, Laura, Gonzalez Acera, Miguel, Neurath, Markus, Regensburger, Martin, Krach, Florian, Winner, Beate
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105476/ https://www.ncbi.nlm.nih.gov/pubmed/35562917 http://dx.doi.org/10.3390/ijms23094526

Ejemplares similares

Modeling Cell-Cell Interactions in Parkinson’s Disease Using Human Stem Cell-Based Models
por: Simmnacher, Katrin, et al.
Publicado: (2020)

Zooming in on Cryopreservation of hiPSCs and Neural Derivatives: A Dual‐Center Study Using Adherent Vitrification
por: Kaindl, Johanna, et al.
Publicado: (2018)

Targeted Integration of Inducible Caspase-9 in Human iPSCs Allows Efficient in vitro Clearance of iPSCs and iPSC-Macrophages
por: Lipus, Alexandra, et al.
Publicado: (2020)

Lucky iPSCs
por: Zviran, Asaf, et al.
Publicado: (2014)

iPSCs are safe!
por: Yan, Hualong, et al.
Publicado: (2017)

Microglia Development and Maturation and Its Implications for Induction of Microglia-Like Cells from Human iPSCs
por: Wurm, Johannes, et al.
Publicado: (2021)

Differentiation of human iPSCs into functional podocytes
por: Rauch, Caroline, et al.
Publicado: (2018)

Mitochondria fingerprint longevity in iPSCs
por: Masotti, Andrea, et al.
Publicado: (2015)

Applications of iPSCs in Cancer Research
por: Kim, Jean J
Publicado: (2015)

Reducing genomic instability in iPSCs
por: Ruiz, Sergio, et al.
Publicado: (2015)

The Challenge of Bringing iPSCs to the Patient
por: Ortuño-Costela, María del Carmen, et al.
Publicado: (2019)

iPSCs in Modeling and Therapy of Osteoarthritis
por: Csobonyeiova, Maria, et al.
Publicado: (2021)

Reprogramming efficiency and pluripotency of mule iPSCs over its parents
por: Zhang, Jia, et al.
Publicado: (2023)

Tideglusib Rescues Neurite Pathology of SPG11 iPSC Derived Cortical Neurons
por: Pozner, Tatyana, et al.
Publicado: (2018)

iPSCs: From Bench to Clinical Bed
por: Li, Yujing, et al.
Publicado: (2016)

Axon-Specific Mitochondrial Pathology in SPG11 Alpha Motor Neurons
por: Güner, Fabian, et al.
Publicado: (2021)

Efficient Precision Genome Editing in iPSCs via Genetic Co-targeting with Selection
por: Mitzelfelt, Katie A., et al.
Publicado: (2017)

Nanog-Independent Reprogramming to iPSCs with Canonical Factors
por: Carter, Ava C., et al.
Publicado: (2014)

Disease, iPSCs and a Quest for the Perfect Model
Publicado: (2016)

Clinical Therapy Using iPSCs: Hopes and Challenges
por: Lu, Xiao, et al.
Publicado: (2013)

The Potential of iPSCs for the Treatment of Premature Aging Disorders
por: Compagnucci, Claudia, et al.
Publicado: (2017)

The tale of autologous iPSCs: A monkey perspective
por: Li, Fei
Publicado: (2014)

Tumorigenicity risk of iPSCs in vivo: nip it in the bud
por: Zhong, Chaoliang, et al.
Publicado: (2022)

Functional genomics and the future of iPSCs in disease modeling
por: Brooks, Imogen R., et al.
Publicado: (2022)

Modelling urea cycle disorders using iPSCs
por: Duff, Claire, et al.
Publicado: (2022)

iPSCs in NK Cell Manufacturing and NKEV Development
por: Boyd-Gibbins, Nicholas, et al.
Publicado: (2022)

MSCs vs. iPSCs: Potential in therapeutic applications
por: Thanaskody, Kalaiselvaan, et al.
Publicado: (2022)

Identifying the dynamics of actin and tubulin polymerization in iPSCs and in iPSC-derived neurons
por: Magliocca, Valentina, et al.
Publicado: (2017)

Imidazopyridines as Potent KDM5 Demethylase Inhibitors Promoting Reprogramming Efficiency of Human iPSCs
por: Dabiri, Yasamin, et al.
Publicado: (2019)

Efficient manipulation of gene dosage in human iPSCs using CRISPR/Cas9 nickases
por: Ye, Tao, et al.
Publicado: (2021)

Simple and efficient differentiation of human iPSCs into contractible skeletal muscles for muscular disease modeling
por: Rashid, Muhammad Irfanur, et al.
Publicado: (2023)

Deficiency in MT5-MMP Supports Branching of Human iPSCs-Derived Neurons and Reduces Expression of GLAST/S100 in iPSCs-Derived Astrocytes
por: Arnst, Nikita, et al.
Publicado: (2021)

Human transcription factors responsive to initial reprogramming predominantly undergo legitimate reprogramming during fibroblast conversion to iPSCs
por: Cevallos, Ricardo R., et al.
Publicado: (2020)

Modelling DMD-associated cardiomyopathy in patient-derived iPSCs
Publicado: (2015)

The State of Play with iPSCs and Spinal Cord Injury Models
por: Hodgetts, Stuart I., et al.
Publicado: (2015)

An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs
por: Menon, Siddharth, et al.
Publicado: (2016)

Epigenetic Modifiers Facilitate Induction and Pluripotency of Porcine iPSCs
por: Mao, Jian, et al.
Publicado: (2016)

Apoptosis in Porcine Pluripotent Cells: From ICM to iPSCs
por: Kim, Eunhye, et al.
Publicado: (2016)

Microhomology-assisted scarless genome editing in human iPSCs
por: Kim, Shin-Il, et al.
Publicado: (2018)

The rebirth of iPSCs: Towards a healthier epigenetic landscape
por: Li, Fei
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_aumdhhc5la3v6ine23q042ktm5